145 related articles for article (PubMed ID: 10080317)
1. Examining the secretor status in the saliva of patients with oral pre-cancerous lesions.
Vidas I; Delajlija M; Temmer-Vuksan B; Stipetić-Mravak M; Cindrić N; Maricíć D
J Oral Rehabil; 1999 Feb; 26(2):177-82. PubMed ID: 10080317
[TBL] [Abstract][Full Text] [Related]
2. Examining the presence of ABO(H) antigens of blood types in the saliva of patients with oral cancer.
Cerović R; Juretić M; Balen S; Belusić M; Caser L; Rogić M
Coll Antropol; 2008 Jun; 32(2):509-12. PubMed ID: 18756902
[TBL] [Abstract][Full Text] [Related]
3. Expression of the gene encoding secretor type galactoside 2 α fucosyltransferase (FUT2) and ABH antigens in patients with oral lesions.
Campi C; Escovich L; Moreno A; Racca L; Racca A; Cotorruelo C; Biondi C
Med Oral Patol Oral Cir Bucal; 2012 Jan; 17(1):e63-8. PubMed ID: 22157667
[TBL] [Abstract][Full Text] [Related]
4. The secretor status of blood group antigens in the saliva in people with oral cancers: a systematic review.
Walpola T; Jayawardene KLTD; Weerasekara I
Syst Rev; 2024 Jan; 13(1):13. PubMed ID: 38167167
[TBL] [Abstract][Full Text] [Related]
5. [Precancerous lesions of the oral mucosa].
Laufer J
Actual Odontostomatol (Paris); 1982; 36(137):23-34. PubMed ID: 7102433
[No Abstract] [Full Text] [Related]
6. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
Rai B; Kaur J; Jacobs R; Singh J
J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
[TBL] [Abstract][Full Text] [Related]
7. Secretor status and oral cancer.
Lamey PJ; Douglas PS; Napier SS
Br J Oral Maxillofac Surg; 1994 Aug; 32(4):214-7. PubMed ID: 7947564
[TBL] [Abstract][Full Text] [Related]
8. Analysis of salivary secretor status in patients with oral submucous fibrosis: a case-control study.
Hallikeri K; Udupa R; Guttal K; Naikmasur V
J Investig Clin Dent; 2015 Nov; 6(4):261-6. PubMed ID: 24850779
[TBL] [Abstract][Full Text] [Related]
9. Secretor status and ABH antigens expression in patients with oral lesions.
Campi C; Escovich L; Valdés V; García Borrás S; Racca L; Racca A; Cotorruelo C; Biondi C
Med Oral Patol Oral Cir Bucal; 2007 Oct; 12(6):E431-4. PubMed ID: 17909508
[TBL] [Abstract][Full Text] [Related]
10. Definition of leukoplakia and related lesions: an aid to studies on oral precancer.
Kramer IR; Lucas RB; Pindborg JJ; Sobin LH
Oral Surg Oral Med Oral Pathol; 1978 Oct; 46(4):518-39. PubMed ID: 280847
[No Abstract] [Full Text] [Related]
11. A histologic study of epithelial dysplasia in oral lichen planus.
Odukoya O; Gallagher G; Shklar G
Arch Dermatol; 1985 Sep; 121(9):1132-6. PubMed ID: 4037838
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Salivary Secretor Status of Blood Group Antigens in Patients with Oral Lichen Planus.
Bakhtiari S; Toosi P; Dolati F; Bakhshi M
Med Princ Pract; 2016; 25(3):266-9. PubMed ID: 26554378
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
14. Premalignant lesions of the oral mucosa.
Jolly M
Aust Dent J; 1976 Oct; 21(5):414-22. PubMed ID: 1070974
[TBL] [Abstract][Full Text] [Related]
15. [Epithelial dysplasia and cancerous changes in oral lichen planus: a clinico-pathologic study of 7 cases].
Wen HL
Zhonghua Kou Qiang Yi Xue Za Zhi; 1989 Mar; 24(2):112-4. PubMed ID: 2512077
[No Abstract] [Full Text] [Related]
16. Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects.
Burford-Mason AP; Weber JC; Willoughby JM
J Med Vet Mycol; 1988 Feb; 26(1):49-56. PubMed ID: 3288742
[TBL] [Abstract][Full Text] [Related]
17. Oral Candida carriage and blood group antigen secretor status.
Ben-Aryeh H; Blumfield E; Szargel R; Laufer D; Berdicevsky I
Mycoses; 1995; 38(9-10):355-8. PubMed ID: 8569809
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ABO blood grouping and secretor status in the saliva of the patients with oral potentially malignant disorders.
Rai P; Acharya S; Hallikeri K
J Oral Maxillofac Pathol; 2015; 19(2):164-9. PubMed ID: 26604491
[TBL] [Abstract][Full Text] [Related]
19. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of diagnostic value of AgNOR and PAP in early detection of dysplastic changes in leukoplakia and lichen planus - a preliminary case-control study.
Rao DS; Ali IM; Annigeri RG
J Oral Pathol Med; 2017 Jan; 46(1):56-60. PubMed ID: 27238079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
